🌍·17h agoIndustry
Pharming Group receives positive CHMP opinion for Joenja® (leniolisib) for the treatment of APDS in adult and pediatric patients 12 years and older
Publisher
P
Pharming Group
Global
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on pharming.com
Leave the platform to read the original full article on the publisher site.
Source: Pharming Group
Scope: Industry
Related coverage
More related coverage
GSK RSS·5h ago
27 March 2026Bepirovirsen accepted for review by the European Medicines Agency as a potential first-in-class treatment for chronic hepatitis BSubmission supported by statistically significant and clinically meaningful functional cure rates in pivotal PhIII B-Well trials
Pharmaceutical Technology·5h ago
Rocket’s gene therapy Kresladi wins FDA approval in rare immune disease
Pharmaceutical Technology·5h ago
Novartis to acquire Excellergy for $2bn upfront
Scrip (Informa Intelligence)·5h ago
AstraZeneca Scores First IL-33 Win In COPD With Tozarakimab
The company has succeeded where rivals have failed by showing impact of the new mechanism in chronic...